期刊
CHEMICO-BIOLOGICAL INTERACTIONS
卷 222, 期 -, 页码 87-96出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2014.10.012
关键词
Anticancer drug; MG-63 human osteosarcoma cells; Mechanisms of action; Polyoxometalates; Copper
资金
- UNLP [11X/554]
- CONICET [PIP 1125]
- ANPCyT from Argentina [PICT 2008-2218, PICT-2010- 0981]
- ANPCyT, Argentina
- AMSUD- PASTEUR
Polyoxometalates (POMs) are early transition metal oxygen anion clusters. They display interesting biological effects mainly related to their antiviral and antitumor properties. On the other hand, copper compounds also show different biological and pharmacological effects in cell culture and in animal models. We report herein for the first time, a detailed study of the mechanisms of action of a copper(II) compound of the group of HPOMs with the formula K7Na3[Cu-4(H2O)(2)(PW9O34)(2)]20H(2)O (PW9Cu), in a model of human osteosarcoma derived cell line, MG-63. The compound inhibited selectively the viability of the osteosarcoma cells in the range of 25-100 mu M (p < 0.01). Besides, we have clearly shown a more deleterious action of PW9Cu on tumor osteoblasts than in normal cells. Cytotoxicity studies also showed deleterious effects for PW9Cu. The increment of reactive oxygen species (ROS) and the decrease of the GSH/GSSG ratio were involved in the antiproliferative effects of PW9Cu. Moreover, the compound caused cell cycle arrest in G(2) phase, triggering apoptosis as determined by flow cytometry. As a whole, these results showed the main mechanisms of the deleterious effects of PW9Cu in the osteosarcoma cell line MG-63, demonstrating that this compound is a promissory agent for cancer treatments. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据